Board Director Zhao Wei of Boai NKY Medical (300109.SZ) received the administrative penalty decision from the Henan Securities Regulatory Bureau.

Boai NKY Medical (300109.SZ) announcement, the company director Zhao Wei has received the "Administrative Penalty Decision" issued by the Henan Regulatory Bureau of the China Securities Regulatory Commission. The decision points out: During Zhao Wei's tenure as director of Boai NKY Medical, Zhao Wei's son Zhao sold a total of 1.2855 million shares of "Boai NKY Medical" stock from July 9 to December 19, 2024, with a total selling amount of 22.33048 million yuan; and bought a total of 0.2385 million shares of "Boai NKY Medical" stock, with a total buying amount of 3.86764 million yuan. The above actions violated the provisions of Article 44, Paragraphs 1 and 2 of the Securities Law, constituting short-term trading behavior as described in Article 189 of the Securities Law. The Henan Regulatory Bureau decided to give a warning to Zhao Wei and impose a fine of 300,000 yuan.